Page last updated: 2024-08-25

clarithromycin and Bright Disease

clarithromycin has been researched along with Bright Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McKenna, KE; Morris, TC; Ramadan, KM1
Krediet, RT; van Westrhenen, R; Weening, JJ1

Other Studies

2 other study(ies) available for clarithromycin and Bright Disease

ArticleYear
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
    The Lancet. Oncology, 2006, Volume: 7, Issue:11

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid

2006
Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:12

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Clarithromycin; Complement C3; Female; Glomerulonephritis; Humans; Kidney Glomerulus; Pneumonia; Pneumonia, Mycoplasma; Renal Dialysis

1998